# Bio-Techne (TECH) operating margin: 22.4% in 2026

URL: https://funkfolio.com/stock/TECH/operating-margin

> Bio-Techne (TECH) operating margin was 22.4% in fiscal 2026, up 2.5 points from fiscal 2025. Its median over 17 fiscal years is 25.6%.

---

## Bio-Techne (TECH) operating margin

**Operating margin · fiscal 2026:** 22.4% year ended Jun 30, 2026

Bio-Techne (TECH) had an operating margin of 22.4% in fiscal 2026 (the year ended June 30, 2026). That is 2.5 percentage points higher than the 19.9% of fiscal 2025. Figures as of 17 Nov 2026, 21:29 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Operating margin, fiscal 2026:** 22.4%
- **Change on fiscal 2025:** +2.5 pts
- **Highest on record:** 58.1% fiscal 2010
- **Lowest on record:** 0.1% fiscal 2013
- **Fiscal years on record:** 18 2009–2026

Figures as of 17 Nov 2026, 21:29 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Bio-Techne operating margin, in more detail

Across the 18 fiscal years on record (2009–2026), the highest was 58.1% in fiscal 2010 and the lowest 0.1% in fiscal 2013. The fiscal 2026 figure is higher than in 41% of the 17 earlier fiscal years on record, whose median is 25.6%.

Gross margin was 65.8% in fiscal 2026. Net margin was 15.0% in fiscal 2026.

### Operating margin by fiscal year

- Operating margin
- Gross margin
- Net margin

### Bio-Techne operating margin, year by year

Bio-Techne (TECH) operating margin by fiscal year

| Fiscal year | Operating margin | Change | Year ended | Gross margin | Net margin |
| --- | --- | --- | --- | --- | --- |
| 2026 | 22.4% | 2.5 pts up | Jun 30, 2026 | 65.8% | 15.0% |
| 2025 | 19.9% | 1.4 pts down | Jun 30, 2025 | 64.8% | 6.0% |
| 2024 | 21.3% | 4.3 pts down | Jun 30, 2024 | 66.4% | 14.5% |
| 2023 | 25.6% | 1.2 pts down | Jun 30, 2023 | 67.7% | 25.1% |
| 2022 | 26.8% | 1.3 pts up | Jun 30, 2022 | 68.4% | 24.6% |
| 2021 | 25.5% | 4.2 pts up | Jun 30, 2021 | 68.0% | 15.1% |
| 2020 | 21.3% | 0.8 pts up | Jun 30, 2020 | 65.4% | 31.0% |
| 2019 | 20.5% | 0.6 pts down | Jun 30, 2019 | 66.3% | 13.5% |
| 2018 | 21.2% | 0.2 pts down | Jun 30, 2018 | 67.2% | 19.6% |
| 2017 | 21.4% | 8.8 pts down | Jun 30, 2017 | 66.5% | 13.5% |
| 2016 | 30.2% | 2.3 pts down | Jun 30, 2016 | 67.5% | 20.9% |
| 2015 | 32.5% | 12.1 pts down | Jun 30, 2015 | 67.9% | 23.8% |
| 2014 | 44.7% | 44.6 pts up | Jun 30, 2014 | 70.3% | 31.0% |
| 2013 | 0.1% | 52.8 pts down | Jun 30, 2013 | 74.4% | 36.2% |
| 2012 | 52.8% | 3.4 pts down | Jun 30, 2012 | 75.0% | 35.7% |
| 2011 | 56.2% | 1.9 pts down | Jun 30, 2011 | 77.6% | 38.7% |
| 2010 | 58.1% | 1.0 pts up | Jun 30, 2010 | 79.6% | 40.8% |
| 2009 | 57.1% | — | Jun 30, 2009 | 78.8% | 39.9% |

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

### How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

### Operating margin at health care companies of similar size

Operating margin of Bio-Techne and comparable companies

| Company | Operating margin | Fiscal year |
| --- | --- | --- |
| [DaVita DVA](https://funkfolio.com/stock/DVA/operating-margin) | 14.7% | 2025 |
| [Halozyme Therapeutics HALO](https://funkfolio.com/stock/HALO/operating-margin) | 57.5% | 2025 |
| [Universal Health Services UHS](https://funkfolio.com/stock/UHS/operating-margin) | 11.5% | 2025 |
| [Repligen RGEN](https://funkfolio.com/stock/RGEN/operating-margin) | 5.6% | 2025 |
| Bio-Techne TECH | 22.4% | 2026 |
| [BioMarin Pharmaceutical BMRN](https://funkfolio.com/stock/BMRN/operating-margin) | 12.7% | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Bio-Techne, figure by figure

- [Bio-Techne market cap](https://funkfolio.com/stock/TECH/market-cap)
- [Bio-Techne revenue](https://funkfolio.com/stock/TECH/revenue)
- [Bio-Techne earnings](https://funkfolio.com/stock/TECH/earnings)
- [Bio-Techne earnings per share (EPS)](https://funkfolio.com/stock/TECH/eps)
- [Bio-Techne P/E ratio](https://funkfolio.com/stock/TECH/pe-ratio)
- [Bio-Techne P/S ratio](https://funkfolio.com/stock/TECH/ps-ratio)
- [Bio-Techne P/B ratio](https://funkfolio.com/stock/TECH/pb-ratio)
- [Bio-Techne free cash flow](https://funkfolio.com/stock/TECH/free-cash-flow)
- [Bio-Techne dividend](https://funkfolio.com/stock/TECH/dividend)
- [Bio-Techne shares outstanding](https://funkfolio.com/stock/TECH/shares-outstanding)
- [Bio-Techne total debt](https://funkfolio.com/stock/TECH/total-debt)
- [Bio-Techne cash on hand](https://funkfolio.com/stock/TECH/cash)
- [Bio-Techne total assets](https://funkfolio.com/stock/TECH/total-assets)
- [Bio-Techne return on equity (ROE)](https://funkfolio.com/stock/TECH/roe)
- [Bio-Techne return on invested capital (ROIC)](https://funkfolio.com/stock/TECH/roic)

[Bio-Techne (TECH) overview: price, valuation and scorecard](https://funkfolio.com/stock/TECH) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Bio-Techne operating margin: questions and answers

**What is Bio-Techne's operating margin?**

Bio-Techne (TECH) had an operating margin of 22.4% in fiscal 2026 (the year ended June 30, 2026). That is 2.5 percentage points higher than the 19.9% of fiscal 2025.

**Is Bio-Techne's operating margin high or low compared with its own history?**

The fiscal 2026 figure is higher than in 41% of the 17 earlier fiscal years on record, whose median is 25.6%.

**What are the highest and lowest operating margin figures on record for Bio-Techne?**

Across the 18 fiscal years on record (2009–2026), the highest was 58.1% in fiscal 2010 and the lowest 0.1% in fiscal 2013.

**What are Bio-Techne's gross and net margins?**

Gross margin was 65.8% in fiscal 2026. Net margin was 15.0% in fiscal 2026.

**How is Bio-Techne's operating margin calculated?**

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

### Learn: operating margin

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Bio-Techne (TECH) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/TECH/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.
